This funding supports research projects designed to provide necessary and sufficient information to plan Phase II-IV clinical trials focused on efficacy, safety, clinical management, or implementation of interventions for heart, lung, blood, and sleep disorders. The R34 mechanism funds studies that answer scientific or operational questions to inform future trials. Support for the subsequent clinical trial requires a new application.
Eligible applicants include for-profit organizations (excluding small businesses), Native American tribal organizations, private and public institutions of higher education, government entities at various levels, nonprofits with and without 501(c)(3) status, small businesses, and housing authorities
